
    
      Do mesenchymal stem cells accelerate new bone formation in persistent non-unions treated with
      carrier plus in vitro expanded autologous BMSCs or carrier alone (control). Secondary aims
      were to analyze predictors of union in these patients and describe adverse events at final
      follow-up.
    
  